top life sciences private equity firmsclubman pinaud cologne

Healthcare companies in its portfolio include IMS, a provider of outsourced hospitalist physicians programs to acute care facilities and community primary care physicians throughout Northern Ohio, and Resonetics, which provides laser micromachining manufacturing services for medical device and diagnostic companies. Others, such as Solid Biosciences and Marinus Pharmaceuticals, are developing drugs for rare genetic disorders that affect the central nervous system. It considers a broad range of investments in companies in the provider services and non-reimbursement healthcare industries, as well as hospitals and other major facilities. More information about Sverica is available at www.sverica.com. Topics covered: Pharma, biotech, FDA, gene therapy, clinical trials, drug pricing and much more. The firm is flexible on its investment size in middle-market companies. With offices in Dallas and Nashville, this physician-founded firm pursues control equity and mezzanine investments. Healthcare companies in the Pamlico portfolio include HEALTHCAREfirst, a provider of SaaS solutions and services to home health and hospice agencies; Physicians Endoscopy, a developer, manager and owner of freestanding, single-specialty endoscopic ASCs; and VRI (Valued Relationships Inc.), a provider of telehealth monitoring, monitored medication dispensing and adherence solutions, and medical alert systems. Read more about ABS at Founded in 1989, Abry focuses on lower middle market companies in healthcare and other industries. What are you looking This column is the first in a multi-part series (part two is accessible here; part three is accessible here; part four is accessible here) we will be publishing in 2016 which highlights some of the more active private equity investors in the healthcare and life science space. Privacy Policy. Spanos Barber Jesse & Co. (SBJ) SBJ, which has offices in the San Francisco Bay area and Dallas, has broad flexibility on investment size in the lower to middle market. Companies in its current portfolio include Pediatric Therapy Services, a provider of therapy services to a variety of public school districts and private learning centers; Southern Veterinary Partners, a support organization for general veterinary practices in the Southeast; Chicagoland Smile Group, a dental support organization in Chicago; Florida Autism Centers, a provider of center-based applied behavior analysis treatment to children diagnosed with Autism Spectrum Disorder; and IZI Medical Products, a developer, manufacturer and provider of medical consumable accessories used in radiology, radiation therapy and image-guided surgery procedures. Subscribe to BioPharma Dive for top news, trends & analysis, The free newsletter covering the top industry headlines, Vial adds Dr. Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory, Vial Adds Dr. Jeffrey Heier of OCB to their Ophthalmology CRO Advisory Board, Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies, FDA Accepts Byondis Biologics License Application for [Vic-]Trastuzumab Duocarmazine (SYD985. ORIX Healthcare considers a wide range of control and minority equity investments in the life sciences/pharmaceutical industry and companies that live in the healthcare sector but do not have direct reimbursement risk. American and its affiliates prefer to make more substantial investments from a dollars perspective. The firm seeks control equity investments in healthcare companies in the provider services industry and companies that live in the healthcare sector but do not have direct reimbursement risk, while also investing in other non-healthcare industries. Using data from Pitchbook, Healthcare Dive found private equity deals in the space more than doubled in the decade between 2008 and 2018, ultimately surpassing $100 billion in total value by that latter year. Included in its portfolio is Jefferson Dental Clinics, a network of over 40 clinics in the Dallas/Fort Worth and Houston, Texas, metro areas, and Bright Now! Geneva Glen Capital Founded in 2008, Geneva Glen is a Chicago-based firm that that invests in lower middle-market companies in numerous industries, including healthcare. By continuing to use our site, you acknowledge that you have read, that you understand, and that you accept our. Bain's new haul is the most recent example of private equity's growing interest in drug development. Amber Walsh is the former Chairwoman of the firms Healthcare Department, one of the largest healthcare practices in the United States. The firm targets companies within healthcare and more than a dozen other industries. More information about High Street is available at www.highstreetcapital.com. Past healthcare investments include BeneSys, which provides healthcare payment processing as a third-party administrator and software and computer services to multi-employer unions and voluntary employee beneficiary associations, and Countryside Hospice, which provides home hospice care in rural and suburban communities in the Southeastern United States. Note: To recommend a firm to be profiled in a future column or request a change to a profile, please email [email protected] or fill out the form here. And within healthcare, biotech appears to be a focus. Sheridan Capital Partners (Chicago): 79. Companies within EDGs portfolio include DiabetesAmerica, a health center and management program for individuals with diabetes; FirstCall Ambulance Service, a provider of scheduled, non-emergency ambulance and medical transport services; MMIS, a provider of cloud-based SaaS solutions for pharmaceutical, medical device and bio-pharmaceutical companies; and Peak Health Solutions, a health information management services company providing solutions in the areas of coding, compliance and CDI. High Road Capital Partners Founded in 2007 and based in New York, High Road Capital Partners invests in healthcare and several other industries through lower middle-market transactions. More information about Shore is available at www.shorecp.com. More information about Riata is available at www.riatacapital.com. Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe. www.americancapital.com, Founded in 2015, Amerigo seeks to make control investments in lower middle market companies. Within healthcare, Sverica targets companies in the provider services and non-reimbursement healthcare industries, as well as hospitals and other major facilities. In addition to healthcare services, High Street also pursues investments in other industries, including niche manufacturing and outsourced business services. Second quarter reports could bring questions on a reportedly forthcoming $40 billion takeover, GSKs new slimmed-down look and market uptake for expected blockbustersfrom Lilly and Bristol Myers. More information about Riverside is available at www.riversidecompany.com. Last year, Blackstone. Companies in its healthcare portfolio include LabConnect, a provider of central laboratory and support services to biopharmaceutical, medical device and contract research organizations; ConnectYourCare, a consumer-directed healthcare account administrator; and Bravo Wellness, a corporate wellness provider. Bain, for example, provided $350 million to getCerevel Therapeutics, a neuroscience company spun out of Pfizer's laboratories, off the ground. More information about EEF is available at www.enhancedequity.com. The firm has eight offices in the United States, Europe and Asia. He has a wide scope of experience spanning mergers and acquisitions, senior and mezzanine lending, venture capital investments and private equity fund formation. More information about SBJ is available at www.sbjcap.com. www.ahpartners.com. And within healthcare, biotech appears to be a focus. Please check it out! The firm seeks minority and control equity investments in healthcare companies offering provider services as well as in ambulatory surgery centers and multi-site healthcare providers. Altaris is flexible in its investment sizes. Companies in its healthcare portfolio include Lighthouse Autism Center, a provider of center-based applied behavioral analysis therapy for children on the autism spectrum; Anju, a provider of data and application software to life sciences companies, contract research organizations and medical device manufacturers; North American Dental Group, a provider of dental services in several states; and ADURO, a provider of health, wellbeing and performance solutions for enterprise employers. Based in Los Angeles, the firm weighs a wide range of investments in healthcare services and several other industries. Read more about Apple Tree at , By signing up to receive our newsletter, you agree to our, Webinar Two years later, the firm topped off a second fund at $1.1 billion. Pamlico Capital Founded in 1988 and based in Charlotte, N.C., Pamlico considers a wide range of investments in the lower to middle market. Based in Baltimore, the firm targets companies in healthcare and a few other industries. MTS invests in a broad range of industry segments including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution. Within healthcare, Riverside pursues investments in provider services and non-reimbursement healthcare industries, specifically within companies providing dermatology, dental and behavioral services, as well as providers of life sciences/pharmaceutical services. All Rights Reserved. LaSalle Capital Founded in 2004, LaSalle Capital is a Chicago-based firm with wide flexibility on investment size in the lower to middle market. Elm Creeks healthcare portfolio includes Millennium Healthcare Management, which operates and manages multiple urgent care clinics in Southern Louisiana. Companies in its portfolio include Allied Digestive Health, a multi-specialty physician group; Cardiovascular Health Partners, a cardiovascular health services platform; DeliverHealth, a provider of professional and tech-enabled services designed to simplify EHR, revenue cycle and patient engagement complexities for health systems; and Clear Health Strategies, a tech-enabled payor services platform designed for managing non-standard medical claims. Get the free daily newsletter read by industry experts. More information about High Road Capital Partners is available at www.highroadcap.com. | 2:00PM ET, $135 million financing for Amylyx Pharmaceuticals, Pfizer, Bain Capital launch neuroscience company backed with $350M, Blackstone caps off private equity's largest-ever life sciences fund, Biogen, citing insurance challenges, shutters one of its Aduhelm studies, Drug deals, launches in focus as pharma earnings begin, Novartis asks FDA to approve biosimilar for Biogen's top-selling MS drug, 'Flat is the new up': After biotech correction, venture investors turn to safer bets, Epigenetic editing: a tunable CRISPR alternative, Sarepta to ask FDA for accelerated approval of Duchenne gene therapy, Decentralization: The Evolution of Clinical Trial Design, Optimizing Engagement: How To Plan Successful Meetings and Events in Biopharma Today, The latest developments in oncology research, Biden Administration Plans to Offer Updated Booster Shots in September, Califf warns of dangers of user fee brinkmanship, This billionaire has quietly driven Bostons biotech industry for decades, Build An Effective Drug Discount Management Program for Your Organization, Addressing Personalized Medicines Complexity Problem: Examples from Parkinsons Disease, 2022 PDA Rapid Microbiological Methods Workshop, Focus on genomic innovation, not on undifferentiated heavy lifting, Innovate with tools and solutions purpose-built for life sciences organizations, Concert to seek approval for hair loss drug after second study success, Alnylam reveals longer wait for anticipated drug trial results, Novartis-linked startup launches with technology designed to remove destroy tags on helpful proteins, Boston-based investment firm Bain Capital has raised $1.9 billion in a new fund directed at pharmaceutical, biotechnology and medical device companies. HIG Capital Founded in 1993 and based in Miami, HIG pursues investments in a wide range of industries. Cookie Policy. Within healthcare, the firm targets companies in the life sciences/pharmaceutical and non-reimbursement healthcare industries. The firm makes investments in a wide range of industries, with its healthcare investing targeting the provider services and life sciences/pharmaceutical industries. More information about Gemini is available at www.gemini-investors.com. The Becker's Hospital Review website uses cookies to display relevant ads and to enhance your browsing experience. The firm seeks minority or control equity investments in healthcare companies in the pharmaceutical, provider services and non-reimbursement healthcare industries, and invests in companies in other industries as well. www.altariscap.com, Founded in 2011, AMC pursues control investments or significant minority investments in middle market companies in healthcare and several other sectors. More information about Pharos is available at www.pharosfunds.com. The firm seeks minority or control equity or mezzanine investments in healthcare companies in the provider services and non-reimbursement healthcare industries as well as in hospitals. Based in Greenwich, Conn., the firm prefers to make more substantial investments from a dollars perspective in companies with EBITDA of $10 million to $75 million. Enhanced Equity Funds (EEF) Founded in 2005 and based in New York, EEF is focused exclusively on investing in the lower-middle market healthcare industry. For more information and to learn how you can change your cookie settings, please see our policy. Leading Private Equity Firms That Invest in Healthcare (Part I), Healthcare & Life Sciences Private Equity Deal Tracker: Riverside Company Acquires Rockpointe, Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Invests in Ephicacy, Healthcare & Life Sciences Private Equity Deal Tracker: Amulet Capital Sells OPEN Health, Subscribe to The Healthcare Investor by Email, Leading Private Equity Investors in Healthcare website, www.orix.com/capital-solution/healthcare/. Based in Irvine, Calif., the firm targets companies with EBITDA from $2 million to $20 million across a variety of industries, including biotech, pharmaceutical and healthcare IT. Read more about Assured at Companies in its portfolio include NextCare, an independent urgent care provider with clinics across six states; Regency Healthcare Group, a provider of hospice and palliative care services; and West Dermatology, a physician practice management company that operates dermatology clinics in Nevada, Arizona and California. The firm focuses exclusively on healthcare, pursuing investments in the provider services, non-reimbursement healthcare and life sciences/pharmaceutical industries, as well as hospitals and other major facilities. They are listed in no particular order, and additional investors will be discussed in future segments of the series. More information about Altaris is available at www.altariscap.com. Silver Oak Services Partners Founded in 2006, Silver Oak seeks control equity in healthcare services, business and consumer companies in the lower middle market. 2012-2022 Bain Capital, LP. Companies in its portfolio include Flow Polymers, a manufacturer of chemical dispersions, process aids and homogenizing agents for pharmaceutical and other markets. Companies in its portfolio include Virtus Pharmaceuticals, a specialty generics pharmaceutical company; Strata, a full-service anatomic pathology laboratory focused on the dermatology, urology, podiatry, oral pathology, gastroenterology and gynecology segments; and CORPAK MedSystems, a medical device company focused on enteral access technologies. Included in its portfolio is MetaSource, a provider of technology-enabled business process outsourcing services with a focus on the healthcare, financial services and retail industries. Log in to access your account information. More information about Silver Oak is available at www.silveroaksp.com. The last several years have seen private equity grow more entrenched in healthcare. More information about LLR is available at www.llrpartners.com. Companies in its portfolio include Seaside Healthcare, an owner, developer and operator of a network of facilities specializing in mental health treatment services for the adult and geriatric population; MOTION Physical Therapy, an outpatient provider of physical and occupational therapy services; Sona Dermatology and MedSpa, a multi-site provider of medical, cosmetic, surgical and pathologic dermatology; and TechLab, a developer and manufacturer of diagnostics products. More specifically, companies of interest include healthcare service, pharmaceutical product and pharmaceutical service providers. With offices in Boston, Chicago and Palm Beach, the firm pursues buyout transactions of growing companies with revenue of at least $20 million. Companies in its portfolio include Aisthesis, a provider of anesthesiology services to ambulatory surgery centers, and IWP, a specialty home delivery pharmacy serving patients injured in accidents covered by property casualty insurance. Indeed, just last month, the firm participated in a $135 million financing for Amylyx Pharmaceuticals, a company whose closely watched drug for amyotrophic lateral sclerosis could be approved in Canada within the next year. Linking and Reprinting Policy.